Rockefeller Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.2M Buy
225,656
+54,573
+32% +$5.86M 0.05% 331
2025
Q1
$17.3M Buy
171,083
+23,009
+16% +$2.32M 0.04% 408
2024
Q4
$13.2M Buy
148,074
+10,110
+7% +$901K 0.03% 465
2024
Q3
$11.5M Buy
137,964
+13,268
+11% +$1.11M 0.03% 506
2024
Q2
$9.59M Buy
124,696
+29,132
+30% +$2.24M 0.03% 525
2024
Q1
$6.55M Buy
95,564
+40,377
+73% +$2.77M 0.02% 620
2023
Q4
$3.19M Buy
55,187
+5,931
+12% +$343K 0.01% 768
2023
Q3
$2.6M Sell
49,256
-52,243
-51% -$2.76M 0.01% 757
2023
Q2
$5.49M Buy
101,499
+37,088
+58% +$2.01M 0.02% 572
2023
Q1
$3.22M Buy
64,411
+19,480
+43% +$974K 0.01% 670
2022
Q4
$2.08M Buy
44,931
+3,673
+9% +$170K 0.01% 737
2022
Q3
$1.6M Buy
41,258
+4,094
+11% +$158K 0.01% 839
2022
Q2
$1.38M Buy
37,164
+5,394
+17% +$201K 0.01% 882
2022
Q1
$1.41M Buy
31,770
+6,022
+23% +$267K 0.01% 937
2021
Q4
$1.09M Sell
25,748
-21,281
-45% -$903K 0.01% 1022
2021
Q3
$2.04M Buy
47,029
+12,069
+35% +$523K 0.01% 741
2021
Q2
$1.49M Buy
34,960
+3,244
+10% +$139K 0.01% 795
2021
Q1
$1.23M Buy
31,716
+3,395
+12% +$131K 0.01% 723
2020
Q4
$1.02M Buy
28,321
+7,596
+37% +$273K 0.01% 684
2020
Q3
$791K Buy
20,725
+8,664
+72% +$331K 0.01% 660
2020
Q2
$423K Buy
12,061
+9,528
+376% +$334K ﹤0.01% 762
2020
Q1
$83K Buy
2,533
+1,180
+87% +$38.7K ﹤0.01% 1072
2019
Q4
$61K Buy
1,353
+361
+36% +$16.3K ﹤0.01% 1099
2019
Q3
$40K Buy
992
+640
+182% +$25.8K ﹤0.01% 1031
2019
Q2
$15K Sell
352
-1,678
-83% -$71.5K ﹤0.01% 1092
2019
Q1
$78K Buy
+2,030
New +$78K ﹤0.01% 816